Evidence map›Paper›PMID 30719864›Full record

ArticleAmerican journal of medical genetics. Part A2019

Hyperinsulinemic hypoglycemia in seven patients with de novo NSD1 mutations.

Katheryn Grand, Christina Gonzalez-Gandolfi, Amanda M Ackermann, Deema Aljeaid, Emma Bedoukian, Lynne M Bird, Diva D De Leon, Jullianne Diaz, Robert J Hopkin, Sejal P Kadakia and 13 more

Abstract readCase Reports
In one paragraph

Article in American journal of medical genetics. Part A, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Hyperinsulinemia in Sotos Syndrome with aJournal of clinical research in pediatric endocrinology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Syndromic forms of congenital hyperinsulinism.Frontiers in endocrinology · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Congenital hyperinsulinism disorders: Genetic and clinical characteristics.American journal of medical genetics. Part C, Seminars in medical genetics · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 2 countries.

Katheryn GrandDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.ORCID 0000-0002-9411-2913
Christina Gonzalez-GandolfiDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Amanda M AckermannDivision of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.ORCID 0000-0002-5614-9790
Deema AljeaidDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.ORCID 0000-0002-0343-6083
Emma BedoukianDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.ORCID 0000-0003-3064-2488
Lynne M BirdDepartment of Pediatrics, Division of Genetics, University of San Diego, California and Rady Children's Hospital, San Diego, California.
Diva D De LeonDivision of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Jullianne DiazRare Disease Institute - Genetics and Metabolism, Children's National Health System, Washington, District of Columbia.ORCID 0000-0001-8329-7775
Robert J HopkinDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Sejal P KadakiaDepartment of Pediatrics, Division of Endocrinology, University of San Diego, California and Rady Children's Hospital, San Diego, California.
Beth KeenaDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Karen O KleinDepartment of Pediatrics, Division of Endocrinology, University of San Diego, California and Rady Children's Hospital, San Diego, California.
Ian KrantzDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Eyby LeonRare Disease Institute - Genetics and Metabolism, Children's National Health System, Washington, District of Columbia.
Katherine LordDivision of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Carey McDougallDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Livija MedneDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Cara M SkrabanDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Charles A StanleyDivision of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Jennifer TarpinianDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Elaine ZackaiDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Matthew A DeardorffDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Jennifer M KalishDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.ORCID 0000-0003-1500-9713
Children's Hospital of Philadelphia · USUniversity of San Diego · USChildren's National · USCincinnati Children's Hospital Medical Center · US

Funding

The Mechanism of Tumor Formation in Beckwith-Wiedemann SyndromeK08CA193915 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI KALISH, JENNIFER MELISSA · 2015 to 2019
$703k
Alex's Lemonade Stand Foundation for Childhood CancerNCI NIH HHS K08 CA193915St. Baldrick's Foundation
6 · The paper itself

Abstract

Sotos syndrome is an overgrowth syndrome characterized by distinctive facial features and intellectual disability caused by haploinsufficiency of the NSD1 gene. Genotype-phenotype correlations have been observed, with major anomalies seen more frequently in patients with 5q35 deletions than those with point mutations in NSD1. Though endocrine features have rarely been described, transient hyperinsulinemic hypoglycemia (HI) of the neonatal period has been reported as an uncommon presentation of Sotos syndrome. Eight cases of 5q35 deletions and one patient with an intragenic NSD1 mutation with transient HI have been reported. Here, we describe seven individuals with HI caused by NSD1 gene mutations with three having persistent hyperinsulinemic hypoglycemia. These patients with persistent HI and Sotos syndrome caused by NSD1 mutations, further dispel the hypothesis that HI is due to the deletion of other genes in the deleted 5q35 region. These patients emphasize that NSD1 haploinsufficiency is sufficient to cause HI, and suggest that Sotos syndrome should be considered in patients presenting with neonatal HI. Lastly, these patients help extend the phenotypic spectrum of Sotos syndrome to include HI as a significant feature.

Indexed as

MutationAdultCongenital HyperinsulinismDevelopmental DisabilitiesFemaleGrowth DisordersHistone-Lysine N-MethyltransferaseHumansInfantInfant, NewbornMalePhenotypePrognosisSotos SyndromeHistone-Lysine N-MethyltransferaseNSD1 protein, humanhyperinsulinismhypoglycemiaNSD1overgrowth syndromesacrococcygeal teratomaSotos syndrome

Identifiers

PMID30719864
PMCPMC6454923
OpenAlexW2913955522

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.